Ad Promo Review in Pharma - How Far is Too Far?

Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.
Key topics include:

1. What is Ad Promo?
2. Chevron decision's influence on FDA/FTC
3. Should administrative agencies cite letters?
4. Can the FDA establish rules after someone challenges them?
5. Uncertainty of Compliance White Space
6. Is regulatory medical advice now just seen as a risk?

Support the show